Otonomy analyst ratings
Otonomy analyst ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/02/2022 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
04/21/2022 | 1959.73% | Oppenheimer | $5 → $6 | Maintains | Outperform |
02/23/2021 | 1788.09% | HC Wainwright & Co. | $10 → $5.5 | Maintains | Buy |
07/07/2020 | 2989.6% | HC Wainwright & Co. | $8 → $9 | Maintains | Buy |
06/16/2020 | 2989.6% | Cantor Fitzgerald | $3 → $9 | Maintains | Overweight |
12/24/2019 | 2646.31% | Oppenheimer | → $8 | Initiates Coverage On | → Outperform |
08/29/2019 | 2646.31% | HC Wainwright & Co. | → $8 | Initiates Coverage On | → Buy |
11/15/2018 | 2989.6% | Cantor Fitzgerald | → $9 | Initiates Coverage On | → Overweight |
03/19/2018 | — | JP Morgan | Downgrades | Neutral → Underweight | |
08/30/2017 | — | JP Morgan | Downgrades | Overweight → Neutral | |
08/15/2017 | — | JP Morgan | Upgrades | Neutral → Overweight |
日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
---|---|---|---|---|---|
08/02/2022 | — | HC Wainwright & Co. | 降级 | 买入 → 中性 | |
04/21/2022 | 1959.73% | 奥本海默 | 5 美元 → 6 美元 | 维持 | 跑赢大盘 |
2021 年 2 月 23 日 | 1788.09% | HC Wainwright & Co. | 10 美元 → 5.5 美元 | 维持 | 购买 |
07/07/2020 | 2989.6% | HC Wainwright & Co. | 8 美元 → 9 美元 | 维持 | 购买 |
06/16/2020 | 2989.6% | 坎托·菲茨杰拉德 | 3 美元 → 9 美元 | 维持 | 超重 |
12/24/2019 | 2646.31% | 奥本海默 | → 8 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
08/29/2019 | 2646.31% | HC Wainwright & Co. | → 8 美元 | 启动覆盖范围开启 | → 购买 |
11/15/2018 | 2989.6% | 坎托·菲茨杰拉德 | → 9 美元 | 启动覆盖范围开启 | → 超重 |
2018 年 3 月 19 日 | — | 摩根大通 | 降级 | 中性 → 体重不足 | |
08/30/2017 | — | 摩根大通 | 降级 | 超重 → 中性 | |
08/15/2017 | — | 摩根大通 | 升级 | 中性 → 超重 |
Otonomy Questions & Answers
Otonomy 问题与解答
The latest price target for Otonomy (NASDAQ: OTIC) was reported by HC Wainwright & Co. on August 2, 2022. The analyst firm set a price target for $0.00 expecting OTIC to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2022年8月2日公布了Otonomy(纳斯达克股票代码:OTIC)的最新目标股价。该分析公司将目标股价设定为0.00美元,预计OTIC将在12个月内跌至0.00美元(可能下跌-100.00%)。去年有两家分析公司公布了评级。
The latest analyst rating for Otonomy (NASDAQ: OTIC) was provided by HC Wainwright & Co., and Otonomy downgraded their neutral rating.
Otonomy(纳斯达克股票代码:OTIC)的最新分析师评级由HC Wainwright & Co. 提供,Otonomy下调了中性评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Otonomy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Otonomy was filed on August 2, 2022 so you should expect the next rating to be made available sometime around August 2, 2023.
分析师在进行了广泛的研究后得出了股票评级,其中包括浏览公开财务报表,与Otonomy的高管和客户交谈,以及听取财报电话会议。大多数分析师每三个月进行一次评级,因此每家公司每年应获得4个评级。Otonomy的最后一次评级是在2022年8月2日提交的,因此您应该预计下一个评级将在2023年8月2日左右公布。
While ratings are subjective and will change, the latest Otonomy (OTIC) rating was a downgraded with a price target of $0.00 to $0.00. The current price Otonomy (OTIC) is trading at is $0.29, which is out of the analyst's predicted range.
尽管评级是主观的,并将发生变化,但最新的Otonomy(OTIC)评级被下调,目标股价为0.00美元至0.00美元。Otonomy(OTIC)当前的交易价格为0.29美元,超出了分析师的预测区间。